Clinical Frailty Score as a Predictor of Mortality among Patients with COVID-19 Presenting to a Tertiary Care Hospital

Clinical Frailty Score among COVID-19 Patients


  • Hasan Farooq Department of Internal Medicine, Jinnah Hospital, Lahore, Pakistan
  • Tanvir Salam Department of Internal Medicine, Jinnah Hospital, Lahore, Pakistan
  • Mashal Salam Department of Internal Medicine, Jinnah Hospital, Lahore, Pakistan
  • Sadaf Iqbal Department of Internal Medicine, Diabetes and Endocrinology, Jinnah Hospital Lahore, Pakistan
  • Muhammad Zahid Jamil Department of Internal Medicine, Diabetes and Endocrinology, Jinnah Hospital Lahore, Pakistan
  • Ismat Ullah Department of Family Medicine, Allama Iqbal Medical College, Lahore, Pakistan



Clinical Frailty Scale, CFS, COVID-19, Mortality


The association of Clinical Frailty Scale (CFS) with COVID-19 mortality has got prognostic value in some research work. National Institute for Heath and Care Excellence (NICE) guidelines suggest use of CFS in making important decisions regarding COVID-19 patients’ management. Objective: To determine the prognostic validity of clinical frailty score with COVID 19 severity among patients presenting to a tertiary care hospital. Methods: It was a comparative cross sectional study carried out at COVID-19 dedicated ICU, HDU and ward, Jinnah Hospital Lahore from January 2021 to June 2021. Forty-eight patients, fulfilling the inclusion criteria, were recruited for the study after informed consent. Subjects were categorized as low and high frailty on basis of CFS score and outcome was evaluated. Data were entered and analyzed using SPSS version 24.0. Results: Among forty-eight subjects included in study, in subjects with age range of 40 - 60 years, 58.3% were having low CFS score and 50.0% were having high score. In low score group, 54.2% had ward stay with nasal or face mask oxygen as compare to 25.0% in high score group. Forty five percent had HDU/CPAP/ BiPAP in low CFS score group as compare to 41.7% and 33.3% required invasive ventilation with high score. (p=.005). Conclusion: COVID-19 patients with high frailty have with increase severity of disease requiring ICU invasive ventilation and increased mortality compared with non-frail patients with COVID-19.


Team E. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) China, 2020. China CDC weekly. 2020 Feb; 2(8): 113-22. doi: 10.46234/ccdcw2020.032

Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. New England Journal of Medicine. 2020 Feb; 382(8): 727–33. doi: 10.1056/nejmoa2001017

Phua J, Weng L, Ling L, Egi M, Lim CM, Divatia JV, et al. Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations. The Lancet Respiratory Medicine. 2020 May; 8(5): 506-17. doi: 10.1016/S2213-2600(20)30161-2

Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet. 2020 Feb; 395(10223): 497-506.

Rajgor DD, Lee MH, Archuleta S, Bagdasarian N, Quek SC. The many estimates of the COVID-19 case fatality rate. The Lancet Infectious Diseases. 2020 Jul; 20(7): 776-7. doi: 10.1016/S1473-3099(20)30244-9

Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. Jama. 2020 Mar; 323(11): 1061-9. doi: 10.1001/jama.2020.1585

Liu K, Fang YY, Deng Y, Liu W, Wang MF, Ma JP, et al. Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province. Chinese Medical Journal. 2020 May; 133(09): 1025-31. doi: 10.1097/CM9.0000000000000744

Morley JE, von Haehling S, Anker SD, Vellas B. From sarcopenia to frailty: a road less traveled. Journal of Cachexia, Sarcopenia and Muscle. 2014 Mar; 5(1): 5-8. doi: 10.1007/s13539-014-0132-3

Dent E, Lien C, Lim WS, Wong WC, Wong CH, Ng TP, et al. The Asia-Pacific clinical practice guidelines for the management of frailty. Journal of the American Medical Directors Association. 2017 Jul; 18(7): 564-75. doi: 10.1016/j.jamda.2017.04.018

Yang J, Zheng YA, Gou X, Pu K, Chen Z, Guo Q, et al. Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis. International Journal of Infectious Diseases. 2020 May; 94: 91-5. doi: 10.1016/j.ijid.2020.03.017

Kalinsky K, Accordino MK, Hosi K, Hawley JE, Trivedi MS, Crew KD, et al. Characteristics and outcomes of patients with breast cancer diagnosed with SARS-Cov-2 infection at an academic center in New York City. Breast Cancer Research and Treatment. 2020 Jul; 182(1): 239-42. doi: 10.1007/s10549-020-05667-6

Petrilli CM, Jones SA, Yang J, Rajagopalan H, O’Donnell L, Chernyak Y, et al. Factors associated with hospitalization and critical illness among 4,103 patients with COVID-19 disease in New York City. MedRxiv. 2020 Jan; (646): 501-2685.

Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The Lancet. 2020 Mar; 395(10229): 1054-62. doi: 10.1016/S0140-6736(20)30566-3

Ortiz-Prado E, Simbaña-Rivera K, Gomez-Barreno L, Rubio-Neira M, Guaman LP, Kyriakidis NC, et al. Clinical, molecular, and epidemiological characterization of the SARS-CoV-2 virus and the Coronavirus Disease 2019 (COVID-19), a comprehensive literature review. Diagnostic Microbiology and Infectious Disease. 2020 Sep; 98(1): 115094. doi: 10.1016/j.diagmicrobio.2020.115094

Baud D, Qi X, Nielsen-Saines K, Musso D, Pomar L, Favre G. Real estimates of mortality following COVID-19 infection. The Lancet Infectious Diseases. 2020 Jul; 20(7): 773. doi: 10.1016/S1473-3099(20)30195-X

Ruan S. Likelihood of survival of coronavirus disease 2019. The Lancet Infectious Diseases. 2020 Jun; 20(6):630-1. doi: 10.1016/S1473-3099(20)30257-7

Wu Z and McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. Jama. 2020 Apr; 323(13): 1239-42. doi: 10.1001/jama.2020.2648

Basic D and Shanley C. Frailty in an older inpatient population: using the clinical frailty scale to predict patient outcomes. Journal of Aging and Health. 2015 Jun; 27(4): 670-85. doi: 10.1177/0898264314558202

Hewitt J, Carter B, McCarthy K, Pearce L, Law J, Wilson FV, et al. Frailty predicts mortality in all emergency surgical admissions regardless of age. An Observational Study. Age and Ageing. 2019 May; 48(3): 388-94. doi: 10.1093/ageing/afy217

Brill SE, Jarvis HC, Ozcan E, Burns TL, Warraich RA, Amani LJ, et al. COVID-19: a retrospective cohort study with focus on the over-80s and hospital-onset disease. BMC Medicine. 2020 Dec; 18(1): 1-9. doi: 10.1186/s12916-020-01665-z

Hewitt J, Carter B, Vilches-Moraga A, Quinn TJ, Braude P, Verduri A, et al. The effect of frailty on survival in patients with COVID-19 (COPE): a multicentre, European, observational cohort study. The Lancet Public Health. 2020 Aug; 5(8): e444-51



DOI: 10.54393/pjhs.v4i01.500
Published: 2023-01-31

How to Cite

Farooq, H. ., Salam, T. ., Salam, M. ., Iqbal, S. ., Zahid Jamil, M. ., & Ullah, I. . (2023). Clinical Frailty Score as a Predictor of Mortality among Patients with COVID-19 Presenting to a Tertiary Care Hospital: Clinical Frailty Score among COVID-19 Patients. Pakistan Journal of Health Sciences, 4(01), 34–37.



Original Article


Most read articles by the same author(s)